tiprankstipranks
Trending News
More News >
Oncopeptides AB (SE:ONCO)
:ONCO
Sweden Market
Advertisement

Oncopeptides AB (ONCO) Technical Analysis

Compare
5 Followers

Summary of all the Indicators

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Oncopeptides AB’s (ONCO) Moving Averages Convergence Divergence (MACD) indicator is 0.26, suggesting Oncopeptides AB is a Buy.
Oncopeptides AB’s (ONCO) 20-Day exponential moving average is 4.73, while Oncopeptides AB’s (ONCO) share price is kr4.04, making it a Sell.
Oncopeptides AB’s (ONCO) 50-Day exponential moving average is 3.92, while Oncopeptides AB’s (ONCO) share price is kr4.04, making it a Buy.

Oncopeptides AB (ONCO) Pivot Points

Aug 22, 2025, 07:13 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.60
4.80
4.92
5.12
5.24
5.44
5.56
Fibonacci
4.80
4.92
5.00
5.12
5.24
5.32
5.44
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Oncopeptides AB (ONCO) Moving Averages

Aug 22, 2025, 07:13 PM
Period
Simple
Exponential
MA5
4.93Sell
4.73Sell
MA10
4.78Sell
4.82Sell
MA20
5.16Sell
4.73Sell
MA50
3.54Buy
3.92Buy
MA100
2.68Buy
3.13Buy
MA200
2.11Buy
2.54Buy
Oncopeptides AB’s (ONCO) 10-Day exponential moving average is 4.82, while Oncopeptides AB’s (ONCO) share price is kr4.04, making it a Sell.
Oncopeptides AB’s (ONCO) 100-Day exponential moving average is 3.13, while Oncopeptides AB’s (ONCO) share price is kr4.04, making it a Buy.
Oncopeptides AB’s (ONCO) stock price is kr4.04 and Oncopeptides AB’s (ONCO) 50-day simple moving average is 3.54, creating a Buy signal.
Oncopeptides AB’s (ONCO) stock price is kr4.04 and Oncopeptides AB’s (ONCO) 100-day simple moving average is 2.68, creating a Buy signal.
Oncopeptides AB’s (ONCO) stock price is kr4.04 and Oncopeptides AB’s (ONCO) 200-day simple moving average is 2.11, creating a Buy signal.

Oncopeptides AB (ONCO) Technical Indicators

Aug 22, 2025, 07:13 PM
Name
Value
Implied Action
RSI (14)
44.58
Neutral
STOCH (9,6)
43.95
Neutral
STOCHRSI (14)
33.61
Neutral
MACD (12,26)
0.26
Buy
ADX (14)
35.18
Neutral
Williams %R
-89.09
Buy
CCI (14)
-146.73
Buy
ATR (14)
0.57
-
Ultimate Oscillator
42.02
Neutral
ROC
-29.86
Sell
Oncopeptides AB’s (ONCO) Relative Strength Index (RSI) is 44.58, creating a Neutral signal.
Oncopeptides AB’s (ONCO) Trend Strength Indicator (ADX) is 35.18, creating a Neutral signal.
Oncopeptides AB’s (ONCO) Commodity Channel Index (CCI) is -146.73, creating a Buy signal.
Oncopeptides AB’s (ONCO) Price Rate of Change (ROC) is -29.86, creating a Sell signal.

FAQ

Is ONCO a Buy, Hold, or Sell?
Based on ONCO’s technical indicators, ONCO is a Hold.
    What is ONCO’s RSI (14)?
    ONCO’s RSI (14) is 44.58, which suggests ONCO is a Neutral.
      What is ONCO’s MACD?
      ONCO’s MACD is 0.26, which suggests ONCO is a Buy.
        What is ONCO’s 5-day moving average?
        ONCO’s 5-day moving average is 4.93, which suggests ONCO is a Sell.
          What is ONCO’s 20-day moving average?
          ONCO 20-day moving average is 5.16, which suggests ONCO is a Sell.
            What is ONCO’s 50-day moving average?
            ONCO’s 50-day moving average is 3.54, which suggests ONCO is a Buy.
              What is ONCO’s 200-day moving average?
              ONCO’s 200-day moving average is 2.11, which suggests ONCO is a Buy.
                What is ONCO’s Williams % R (14)?
                ONCO’s Williams % R (14) is -89.09, which suggests ONCO is a Buy.
                  What is ONCO’s CCI (14)?
                  ONCO’s CCI (14) is -146.73, which suggests ONCO is a Buy.
                    What is the share price of Oncopeptides AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis